Analyze Diet
Journal of xenobiotics2023; 13(1); 148-158; doi: 10.3390/jox13010012

Nanoformulation of a Trypanocidal Drug Isometamidium Chloride Ameliorates the Apurinic-Apyrimidinic DNA Sites/Genotoxic Effects in Horse Blood Cells.

Abstract: Isometamidium chloride (ISM) is a trypanocide for the prophylactic and therapeutic use against vector-borne animal trypanosomosis (mainly Surra caused by ) and African animal trypanosomosis caused by //). ISM was found to be an efficient trypanocide for therapeutic/prophylactic use against trypanosomosis; however, it produces some local and systemic detrimental effects in animals. We synthesized isometamidium chloride-loaded alginate gum acacia nanoformulation (ISM SANPS) to lessen the detrimental side effects of isometamidium chloride (ISM) while treating trypanosomal diseases. We intended to determine the cytocompatibility/toxicity, and DNA deterioration/chromosomal structural or number changes (genotoxicity) of ISM SANPs using mammalian cells in a concentration-dependent manner. Apurinic/apyrimidinic (AP) sites are one of the major types of DNA lesions formed during base excision and repair of oxidized, deaminated, or alkylated bases. The intensity of the cellular AP site is an excellent marker of the deterioration of DNA quality. We thought it pertinent to quantify the AP sites in ISM SANPs-treated cells. Our investigations established a dose-dependent cyto-compatibility or toxicity and DNA impairment (genotoxicity) in ISM SANPs-treated horse peripheral blood mononuclear cells. ISM SANPs were biocompatible at various concentrations tested on the mammalian cells.
Publication Date: 2023-03-02 PubMed ID: 36976161PubMed Central: PMC10057175DOI: 10.3390/jox13010012Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates a nanotechnology-based formulation of the drug Isometamidium chloride (ISM), which is used to treat trypanosomosis in animals. The new formulation is intended to reduce the drug’s side effects while maintaining its efficacy. The researchers assess the new drug formulation’s effect on DNA and chromosomes in mammalian cell samples.

Introduction and Background

  • Trypanosomosis is a disease that affects animals, primarily caused by parasites. Isometamidium chloride (ISM) is a commonly used drug for its treatment.
  • However, the standard ISM drug has several negative side effects including local and systemic effects in animals.
  • To address this, the researchers created a new ISM formulation using nanotechnology. This new formula, called ISM-loaded alginate gum acacia nanoformulation (ISM SANPs), aimed to lessen the side effects of the drug whilst maintaining effectiveness against trypanosomosis.

Objectives and Methods

  • The researchers intended to determine the cytocompatibility/toxicity and genotoxicity (DNA and chromosome changes) of ISM SANPs using mammalian cells in a concentration-dependent manner.
  • The intensity of cellular apurinic/apyrimidinic (AP) sites, gaps in the DNA sequence, is a useful marker of DNA integrity. Therefore, the team decided to measure these sites to assess the DNA damage caused by ISM SANPs.

Results and Findings

  • The researchers found that exposure to ISM SANPs resulted in a dose-dependent cytotoxicity in horse peripheral blood mononuclear cells. This means that higher concentrations of the drug were toxic to cells while lower doses were compatible and safe.
  • They also found dose-dependent genotoxicity, with higher doses causing more DNA damage, indicated by the higher number of AP sites.
  • However, ISM SANPs were found to be biocompatible at various concentrations tested on mammalian cells, suggesting the nanoformulation ameliorates some of the negative side effects of traditional ISM.

Implications of the Study

  • The results reinforce the use of nanotechnology in drug formulation to reduce side effects while maintaining efficacy, an area of particular importance in veterinary medicine for the treatment of diseases like trypanosomosis.
  • Further research could explore in greater detail the genomic effects of ISM SANPs, and the optimal dosage that maximizes efficacy while minimizing harm.

Cite This Article

APA
Singh S, Kumar B, Dilbaghi N, Devi N, Prasad M, Manuja A. (2023). Nanoformulation of a Trypanocidal Drug Isometamidium Chloride Ameliorates the Apurinic-Apyrimidinic DNA Sites/Genotoxic Effects in Horse Blood Cells. J Xenobiot, 13(1), 148-158. https://doi.org/10.3390/jox13010012

Publication

ISSN: 2039-4713
NlmUniqueID: 101701430
Country: Switzerland
Language: English
Volume: 13
Issue: 1
Pages: 148-158

Researcher Affiliations

Singh, Sandeep
  • ICAR-National Research Centre on Equines, Hisar 125001, Haryana, India.
  • Department of Bio & Nano Technology, Guru Jambheshwar University of Science & Technology, Hisar 125001, Haryana, India.
Kumar, Balvinder
  • ICAR-National Research Centre on Equines, Hisar 125001, Haryana, India.
Dilbaghi, Neeraj
  • Department of Bio & Nano Technology, Guru Jambheshwar University of Science & Technology, Hisar 125001, Haryana, India.
Devi, Nisha
  • ICAR-National Research Centre on Equines, Hisar 125001, Haryana, India.
Prasad, Minakshi
  • ICAR-National Research Centre on Equines, Hisar 125001, Haryana, India.
Manuja, Anju
  • ICAR-National Research Centre on Equines, Hisar 125001, Haryana, India.

Grant Funding

  • SR/NM/NS-1064/2011 / Department of Science and Technology

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 23 references
  1. Rathore NS, Manuja A, Manuja BK, Choudhary S. Chemotherapeutic Approaches Against Trypanosoma evansi: Retrospective Analysis, Current Status and Future Outlook.. Curr Top Med Chem 2016;16(20):2316-27.
  2. African Animal Trypanosomiasis. [(accessed on 27 February 2023)]. Available online: https://www.fao.org/3/ah809e/AH809E02.htm.
  3. Berg SS. Structure of Isometamidium (M. and B. 4180A), 7-m-Amidinophenyldiazoamino-2-amino-10-ethyl-9-phenylphenanthridinium Chloride Hydrochloride, the Red Isomer Present in Metamidium.. Nature 1960;188:1106–1107.
    doi: 10.1038/1881106a0google scholar: lookup
  4. Richardson JP. Mechanism of ethidium bromide inhibition of RNA polymerase.. J Mol Biol 1973 Aug 25;78(4):703-14.
    doi: 10.1016/0022-2836(73)90290-8pubmed: 4587136google scholar: lookup
  5. Shapiro TA. Inhibition of topoisomerases in African trypanosomes.. Acta Trop 1993 Sep;54(3-4):251-60.
    doi: 10.1016/0001-706X(93)90097-Upubmed: 7902662google scholar: lookup
  6. Lantz CH, Van Dyke K. Plasmodium berghei: inhibited incorporation of AMP-8- 3 H into nucleic acids of erythrocyte-free malarial parasites by acridines, phenanthridines, and 8-aminoquinolines.. Exp Parasitol 1972 Apr;31(2):255-61.
    doi: 10.1016/0014-4894(72)90116-6pubmed: 5016595google scholar: lookup
  7. Kinabo LD, Bogan JA. Pharmacokinetic and histopathological investigations of isometamidium in cattle.. Res Vet Sci 1988 Mar;44(2):267-9.
    doi: 10.1016/S0034-5288(18)30855-5pubmed: 3387683google scholar: lookup
  8. Homeida AM, El Amin EA, Adam SE, Mahmoud MM. The effect of samorin (isometamedium chloride) on Trypanosoma evansi infection in mice.. Br J Exp Pathol 1980 Aug;61(4):380-9.
    pmc: PMC2041612pubmed: 7426389
  9. Ali BH, Haroun EM. Acute toxicity of samorin (isometamidium chloride) in rabbits.. Comp Biochem Physiol C Comp Pharmacol Toxicol 1984;78(2):419-23.
    doi: 10.1016/0742-8413(84)90109-9pubmed: 6149091google scholar: lookup
  10. Peregrine AS, Ogunyemi O, Whitelaw DD, Holmes PH, Moloo SK, Hirumi H, Urquhart GM, Murray M. Factors influencing the duration of isometamidium chloride (Samorin) prophylaxis against experimental challenge with metacyclic forms of Trypanosoma congolense.. Vet Parasitol 1988 Apr;28(1-2):53-64.
    doi: 10.1016/0304-4017(88)90018-0pubmed: 3388736google scholar: lookup
  11. Jena P, Mohanty S, Mallick R, Jacob B, Sonawane A. Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells.. Int J Nanomedicine 2012;7:1805-18.
    pmc: PMC3356211pubmed: 22619529doi: 10.2147/ijn.s28077google scholar: lookup
  12. Papageorgiou I, Brown C, Schins R, Singh S, Newson R, Davis S, Fisher J, Ingham E, Case CP. The effect of nano- and micron-sized particles of cobalt-chromium alloy on human fibroblasts in vitro.. Biomaterials 2007 Jul;28(19):2946-58.
  13. Singh S, Chopra M, Dilbaghi N, Manuja BK, Kumar S, Kumar R, Rathore NS, Yadav SC, Manuja A. Synthesis and evaluation of isometamidium-alginate nanoparticles on equine mononuclear and red blood cells.. Int J Biol Macromol 2016 Nov;92:788-794.
  14. IC50 Calculator. [(accessed on 7 July 2021)]. Available online: https://www.aatbio.com/tools/ic50-calculator.
  15. Manuja A, Kumar P, Kumar R, Kumar B, Singha H, Sharma RK, Yadav SC. CpG-ODN class C-mediated immunostimulation and its potential against Trypanosoma evansi in equines.. Int Immunopharmacol 2014 Oct;22(2):366-70.
    doi: 10.1016/j.intimp.2014.07.016pubmed: 25066759google scholar: lookup
  16. Lindahl T. Instability and decay of the primary structure of DNA.. Nature 1993 Apr 22;362(6422):709-15.
    doi: 10.1038/362709a0pubmed: 8469282google scholar: lookup
  17. Friedberg EC, Walker GC, Siede W, Wood RD, Schultz RA, Ellenberger T. DNA Repair and Mutagenesis. 2nd ed. ASM Press; Washington, DC, USA: 2006.
  18. Wilson DM 3rd, Bohr VA. The mechanics of base excision repair, and its relationship to aging and disease.. DNA Repair (Amst) 2007 Apr 1;6(4):544-59.
    doi: 10.1016/j.dnarep.2006.10.017pubmed: 17112792google scholar: lookup
  19. Friedberg EC, Aguilera A, Gellert M, Hanawalt PC, Hays JB, Lehmann AR, Lindahl T, Lowndes N, Sarasin A, Wood RD. DNA repair: from molecular mechanism to human disease.. DNA Repair (Amst) 2006 Aug 13;5(8):986-96.
    doi: 10.1016/j.dnarep.2006.05.005pubmed: 16955546google scholar: lookup
  20. Shafirovich V, Kropachev K, Anderson T, Liu Z, Kolbanovskiy M, Martin BD, Sugden K, Shim Y, Chen X, Min JH, Geacintov NE. Base and Nucleotide Excision Repair of Oxidatively Generated Guanine Lesions in DNA.. J Biol Chem 2016 Mar 4;291(10):5309-19.
    doi: 10.1074/jbc.M115.693218pmc: PMC4777862pubmed: 26733197google scholar: lookup
  21. Kusakabe M, Onishi Y, Tada H, Kurihara F, Kusao K, Furukawa M, Iwai S, Yokoi M, Sakai W, Sugasawa K. Mechanism and regulation of DNA damage recognition in nucleotide excision repair.. Genes Environ 2019;41:2.
    doi: 10.1186/s41021-019-0119-6pmc: PMC6346561pubmed: 30700997google scholar: lookup
  22. Surve DH, Jindal AB. Development of cationic Isometamidium chloride loaded long-acting lipid nanoformulation: optimization, cellular uptake, pharmacokinetics, biodistribution, and immunohistochemical evaluation.. Eur J Pharm Sci 2021 Dec 1;167:106024.
    doi: 10.1016/j.ejps.2021.106024pubmed: 34592462google scholar: lookup
  23. Chen H, Yao L, Brown C, Rizzo CJ, Turesky RJ. Quantitation of Apurinic/Apyrimidinic Sites in Isolated DNA and in Mammalian Tissue with a Reduced Level of Artifacts.. Anal Chem 2019 Jun 4;91(11):7403-7410.

Citations

This article has been cited 0 times.